Trials / Completed
CompletedNCT06182631
Clinical Trial Testing Buzzy Bee vs Vapocoolant During IV Placement
A Randomized Clinical Trial of Buzzy Versus Vapocoolant in Pain Relief During Phlebotomy and IV Catheterization in the Pediatric ED
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 172 (actual)
- Sponsor
- State University of New York at Buffalo · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the anxiety and pain levels of patients when using Buzzy with ice, Vapocoolant, and placebo when inserting IV's line for IV fluids and/or phlebotomy in pediatric patients in the pediatric emergency department.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Buzzy Bee | The Buzzy is a vibrating palm-sized device with removable ice wings developed by MMJ Labs Atlanta, GA. It uses Melzack and Wall's Gait Control theorywhich asserts that activation of non-nociceptive fibers can interfere with signals from pain fibers thereby inhibiting pain. |
| DRUG | Vapocoolent | Vapocoolent is a volatile refrigerated liquid, ie ethyl chloride, which is supposed to feel like the skin is numb before insertion of the IV. |
| OTHER | Placebo | A band will be placed on the arm before IV insertion for placebo effect. |
Timeline
- Start date
- 2019-07-15
- Primary completion
- 2021-01-15
- Completion
- 2021-01-15
- First posted
- 2023-12-27
- Last updated
- 2025-10-02
- Results posted
- 2025-01-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06182631. Inclusion in this directory is not an endorsement.